1h Free Analyst Time
The endometriosis drugs market is forecasted to grow by USD 457.9 million during 2024-2029, accelerating at a CAGR of 4.3% during the forecast period. The report on the endometriosis drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing disease prevalence and improved diagnostic paradigms, robust clinical pipeline and innovation in therapeutic modalities, and expanding advocacy, favourable government initiatives, and increased healthcare investment.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The endometriosis drugs market is segmented as below:
By Product
- Hormone therapy
- Analgesics
By Route Of Administration
- Oral
- Injectables
- Others
By Distribution Channel
- Retail pharmacy
- Hospital pharmacy
- Online pharmacy
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the endometriosis drugs market covers the following areas:
- Endometriosis Drugs Market sizing
- Endometriosis Drugs Market forecast
- Endometriosis Drugs Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Product
9 Market Segmentation by Route of Administration
10 Market Segmentation by Distribution Channel
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global endometriosis drugs market: AbbVie Inc., Ananda Pharma, Bayer AG, Debiopharm International SA, Enteris BioPharma Inc., Gedeon Richter Plc, Gesynta Pharma AB, Hope Medicine, Johnson and Johnson Services Inc., Kissei Pharmaceutical Co. Ltd., Neurocrine Biosciences Inc., Nippon Shinyaku Co. Ltd., Novartis AG, Organon and Co., Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Viramal Ltd.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strategic pivot to non-hormonal therapeutic pathways."
According to the report, one of the major drivers for this market is the increasing disease prevalence and improved diagnostic paradigms.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Ananda Pharma
- Bayer AG
- Debiopharm International SA
- Enteris BioPharma Inc.
- Gedeon Richter Plc
- Gesynta Pharma AB
- Hope Medicine
- Johnson and Johnson Services Inc.
- Kissei Pharmaceutical Co. Ltd.
- Neurocrine Biosciences Inc.
- Nippon Shinyaku Co. Ltd.
- Novartis AG
- Organon and Co.
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viramal Ltd
